Fiteni F, Vernerey D, Bonnetain F, Vaylet F, Sennelart H, Tredaniel J, et al. Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients. Eur J Cancer. 2016;52:120–8.
Article
PubMed
Google Scholar
Shi Y, Sun Y. Medical management of lung cancer: experience in China. Thorac Cancer. 2015;6(1):10–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yan L, Xu L. Global efforts in conquering lung cancer in China. Chin J Cancer. 2015;34(7):320–2.
CAS
PubMed
Google Scholar
Wong IC, Ng YK, Lui VW. Cancers of the lung, head and neck on the rise: perspectives on the genotoxicity of air pollution. Chin J Cancer. 2014;33(10):476–80.
CAS
PubMed
PubMed Central
Google Scholar
Chen W, Zheng R, Zeng H, Zhang S. The updated incidences and mortalities of major cancers in China, 2011. Chin J Cancer. 2015;34(11):502–7.
CAS
PubMed
Google Scholar
Yu JB, Soulos PR, Cramer LD, Decker RH, Kim AW, Gross CP. Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer. Cancer. 2015;121(14):2341–9.
Article
PubMed
PubMed Central
Google Scholar
Moro-Sibilot D, Audigier-Valette C, Merle P, Quoix E, Souquet PJ, Barlesi F, et al. Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: comparison of two chemotherapy regimens (IFCT-0702: a randomized phase 3 final results study). Lung Cancer. 2015;89(2):139–45.
Article
PubMed
Google Scholar
Powrozek T, Mlak R, Krawczyk P, Homa I, Ciesielka M, Koziol P, et al. The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patients. Clin Transl Oncol. 2016;18(2):125–31.
Article
CAS
PubMed
Google Scholar
Yin JY, Meng XG, Qian CY, Li XP, Chen J, Zheng Y, et al. Association of positively selected eIF3a polymorphisms with toxicity of platinum-based chemotherapy in NSCLC patients. Acta Pharmacol Sin. 2015;36(3):375–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cao S, Wang C, Ma H, Yin R, Zhu M, Shen W, et al. Genome-wide association study on platinum-induced hepatotoxicity in non-small cell lung cancer patients. Sci Rep. 2015;5:11556.
Article
CAS
PubMed
PubMed Central
Google Scholar
Genestreti G, Di Battista M, Cavallo G, Bartolotti M, Brandes AA. Maintenance therapy in non-small cell lung cancer. Expert Rev Anticancer Ther. 2015;15(7):839–46.
Article
CAS
PubMed
Google Scholar
Germann MW, Johnson CN, Spring AM. Recognition of damaged DNA: structure and dynamic markers. Med Res Rev. 2012;32(3):659–83.
Article
CAS
PubMed
Google Scholar
Perry JR, Hsu YH, Chasman DI, Johnson AD, Elks C, Albrecht E, et al. DNA mismatch repair gene MSH6 implicated in determining age at natural menopause. Hum Mol Genet. 2014;23(9):2490–7.
Article
CAS
PubMed
Google Scholar
Fukuhara S, Chang I, Mitsui Y, Chiyomaru T, Yamamura S, Majid S, et al. DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells. Oncotarget. 2014;5(22):11297–307.
Article
PubMed
PubMed Central
Google Scholar
Heinen CD. Translating mismatch repair mechanism into cancer care. Curr Drug Targets. 2014;15(1):53–64.
Article
CAS
PubMed
Google Scholar
Roesner LM, Mielke C, Fähnrich S, Merkhoffer Y, Dittmar KE, Drexler HG, et al. Stable expression of MutLγ in human cells reveals no specific response to mismatched DNA, but distinct recruitment to damage sites. J Cell Biochem. 2013;114(10):2405–14.
Article
CAS
PubMed
Google Scholar
Buermeyer AB, Deschenes SM, Baker SM, Liskay RM. Mammalian DNA mismatch repair. Annu Rev Genet. 1999;33:533–64.
Article
CAS
PubMed
Google Scholar
Peltomaki P. Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet. 2001;10(7):735–40.
Article
CAS
PubMed
Google Scholar
Larrea AA, Lujan SA, Kunkel TA. SnapShot: DNA mismatch repair. Cell. 2010;141(4):730.e1.
Article
PubMed
Google Scholar
Banasik M, Sachadyn P. Conserved motifs of MutL proteins. Mutat Res. 2014;769:69–79.
Article
CAS
PubMed
Google Scholar
Garcia-Tello A, de Fata FR, Andres G, Ropero S, Lopez JI, Angulo JC. DNA repair genes and prognosis in sporadic forms of urothelial carcinoma of the upper urinary tract. Actas Urol Esp. 2014;38(9):600–7.
Article
CAS
PubMed
Google Scholar
Scarbrough PM, Weber RP, Iversen ES, Brhane Y, Amos CI, Kraft P, et al. A cross-cancer genetic association analysis of the DNA repair and DNA damage signaling pathways for lung, ovary, prostate, breast, and colorectal cancer. Cancer Epidemiol Biomark Prev. 2016;25(1):193–200.
Article
CAS
Google Scholar
Xu XL, Yao YL, Xu WZ, Feng JG, Mao WM. Correlation of MSH3 polymorphisms with response and survival in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Genet Mol Res. 2015;14(2):3525–33.
Article
CAS
PubMed
Google Scholar
Cooley N, Elder RH, Povey AC. The effect of Msh2 knockdown on methylating agent induced toxicity in DNA glycosylase deficient cells. Toxicology. 2010;268(1–2):111–7.
Article
CAS
PubMed
Google Scholar
Tseng-Rogenski SS, Hamaya Y, Choi DY, Carethers JM. Interleukin 6 alters localization of hMSH3, leading to DNA mismatch repair defects in colorectal cancer cells. Gastroenterology. 2015;148(3):579–89.
Article
CAS
PubMed
Google Scholar
Bawa S, Xiao W. A single amino acid substitution in MSH5 results in DNA alkylation tolerance. Gene. 2003;315:177–82.
Article
CAS
PubMed
Google Scholar
Yin JY, Huang Q, Zhao YC, Zhou HH, Liu ZQ. Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients. PLoS ONE. 2012;7(6):e38150.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen J, Yin J, Li X, Wang Y, Zheng Y, Qian C, et al. WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patients. Int J Mol Sci. 2014;15(11):21011–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Y, Yin JY, Li XP, Chen J, Qian CY, Zheng Y, et al. The association of transporter genes polymorphisms and lung cancer chemotherapy response. PLoS ONE. 2014;9(3):e91967.
Article
PubMed
PubMed Central
Google Scholar
Doherty JA, Sakoda LC, Loomis MM, Barnett MJ, Julianto L, Thornquist MD, et al. DNA repair genotype and lung cancer risk in the beta-carotene and retinol efficacy trial. Int J Mol Epidemiol Genet. 2013;4(1):11–34.
PubMed
PubMed Central
Google Scholar
Vogelsang M, Paccez JD, Schafer G, Dzobo K, Zerbini LF, Parker MI. Aberrant methylation of the MSH3 promoter and distal enhancer in esophageal cancer patients exposed to first-hand tobacco smoke. J Cancer Res Clin Oncol. 2014;140(11):1825–33.
Article
CAS
PubMed
Google Scholar